During the past decade, Special Immunizations Program, Division of Medicine, USAMRIID conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Special Immunizations Program, Division of Medicine, USAMRIID" #1 collaborator was "US Army Medical Research Institute of Infectious Diseases" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Special Immunizations Program, Division of Medicine, USAMRIID" are "Eastern Equine Encephalitis" (1 trials), "Q Fever" (1 trials), "Tularemia" (1 trials) and "Venezuelan Equine Encephalomyelitis Virus Disease" (1 trials). Many other conditions were trialed in "Special Immunizations Program, Division of Medicine, USAMRIID" in a lesser frequency.

Most popular intervention types in "Special Immunizations Program, Division of Medicine, USAMRIID" are "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104" (1 trials), "Live Attenuated Tularemia Vaccine" (1 trials), "Q fever Vaccine" (1 trials) and "VEE Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Special Immunizations Program, Division of Medicine, USAMRIID" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Special Immunizations Program, Division of Medicine, USAMRIID". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Special Immunizations Program, Division of Medicine, USAMRIID, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Special Immunizations Program, Division of Medicine, USAMRIID, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".